Abstract
The importance of selenium as essential trace element is today generally recognized. The major biological form of this element is represented by the selenocysteine, incorporated into certain protein having redox motifs. Selenoenzymes are known to catalyze in nature the reduction of peroxides (gluthathione peroxidase) as well the selective deiodination of iodothyronine (iodothyronine deiodinase) and the reduction of dithiol-disulfides (thioredoxin reductase). A variety of organoselenium compounds have been proven to be useful for organic synthesis over several decades. Organoselenium species can be introduced as either nucleophiles or electrophiles to other organic molecules, producing useful intermediates for organic synthesis. Optically active organoselenium derivatives and their application to highly selective asymmetric synthesis are also of current interest. Probably the most interesting aspect, which emerged in recent years, concerns the possibility of effecting some functional group conversions using catalytic amounts of the electrophilic selenium reagent or using selenium containing compounds as chiral ligands in metal catalyzed reactions. The developments of all these catalytic processes probably represent the most important results which have been reported recently in this field. Their conceptual and synthetic relevance considerably increases the importance of organoselenium chemistry and are here reviewed.
Keywords: Selenium, Catalysis, Organocatalysis, Selenoenzyme, Asymmetric Synthesis, gluthathione peroxidase, iodothyronine deiodinase, thioredoxin reductase, selenenylationdeselenenylation reactions, diferrocenyl dichalcogenides, Chiral Diselenides, Selenides, oxazolidine selenides, Chiral phenylselenenyl derivates, Cinchona alkaloids, vinyl cyclopropanes, vinyl aziridines, allylboronic acids, σ-allyl-Pd(II) intermediate, Arylseleninic acids, N-bromosuccinimide (NBS), Glutathione Peroxidase, GPx, phospholipid peroxide, selenenil-sulfide, β-cyclodextrin, Thyronine Deiodinase, selenenyl sulfide, 1,4-dithiothreitol, TrxR, thioredoxin, thioredoxin glutathione reductase, large thioredoxin reductase, selenocysteine
Current Organic Chemistry
Title: Organoselenium Compounds as Catalysts in Nature and Laboratory
Volume: 14 Issue: 20
Author(s): Claudio Santi, Stefano Santoro and Benedetta Battistelli
Affiliation:
Keywords: Selenium, Catalysis, Organocatalysis, Selenoenzyme, Asymmetric Synthesis, gluthathione peroxidase, iodothyronine deiodinase, thioredoxin reductase, selenenylationdeselenenylation reactions, diferrocenyl dichalcogenides, Chiral Diselenides, Selenides, oxazolidine selenides, Chiral phenylselenenyl derivates, Cinchona alkaloids, vinyl cyclopropanes, vinyl aziridines, allylboronic acids, σ-allyl-Pd(II) intermediate, Arylseleninic acids, N-bromosuccinimide (NBS), Glutathione Peroxidase, GPx, phospholipid peroxide, selenenil-sulfide, β-cyclodextrin, Thyronine Deiodinase, selenenyl sulfide, 1,4-dithiothreitol, TrxR, thioredoxin, thioredoxin glutathione reductase, large thioredoxin reductase, selenocysteine
Abstract: The importance of selenium as essential trace element is today generally recognized. The major biological form of this element is represented by the selenocysteine, incorporated into certain protein having redox motifs. Selenoenzymes are known to catalyze in nature the reduction of peroxides (gluthathione peroxidase) as well the selective deiodination of iodothyronine (iodothyronine deiodinase) and the reduction of dithiol-disulfides (thioredoxin reductase). A variety of organoselenium compounds have been proven to be useful for organic synthesis over several decades. Organoselenium species can be introduced as either nucleophiles or electrophiles to other organic molecules, producing useful intermediates for organic synthesis. Optically active organoselenium derivatives and their application to highly selective asymmetric synthesis are also of current interest. Probably the most interesting aspect, which emerged in recent years, concerns the possibility of effecting some functional group conversions using catalytic amounts of the electrophilic selenium reagent or using selenium containing compounds as chiral ligands in metal catalyzed reactions. The developments of all these catalytic processes probably represent the most important results which have been reported recently in this field. Their conceptual and synthetic relevance considerably increases the importance of organoselenium chemistry and are here reviewed.
Export Options
About this article
Cite this article as:
Santi Claudio, Santoro Stefano and Battistelli Benedetta, Organoselenium Compounds as Catalysts in Nature and Laboratory, Current Organic Chemistry 2010; 14 (20) . https://dx.doi.org/10.2174/138527210793358231
DOI https://dx.doi.org/10.2174/138527210793358231 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?
Current Pharmaceutical Design Recent Patents Review on Intranasal Administration for CNS Drug Delivery
Recent Patents on Drug Delivery & Formulation Crosstalk between IGF Signaling and Steroid Hormone Receptors in Breast Cancer
Current Pharmaceutical Design Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers
Current Drug Delivery Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug
Current Topics in Medicinal Chemistry 2-Chloroadenosine and Human Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Relationship between CNS and Immunology: Correlation with Psychology
Current Drug Metabolism Cervical Cancer During Pregnancy – An Approach to Diagnosis and Management
Current Women`s Health Reviews Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure
Current Drug Targets Molecular Functions of BCL10 and MALT1 in Normal and Neoplastic Lymphocytes
Current Immunology Reviews (Discontinued) Regulation of Gene Expression by Retinoids
Current Medicinal Chemistry The Role of NPY and Ghrelin in Anorexia Nervosa
Current Pharmaceutical Design Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Developments in the Mechanism of Anticancer Agents Based on Electron Transfer, Reactive Oxygen Species and Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies
Current Neuropharmacology FAK and p53 Protein Interactions
Anti-Cancer Agents in Medicinal Chemistry EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Current Cancer Drug Targets Gene/Cell Therapy Approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome
Current Gene Therapy